Drug committees should not recommend "off label" prescriptions
Rane, A.
Lakartidningen 103(15-16): 1219
2006
ISSN/ISBN: 0023-7205 PMID: 16696203 Document Number: 596540
Document emailed within 1 workday
Related Documents
Larsson, I.; Ferrándiz, R. 2008: The vast majority of drug committees recommend Anapen Lakartidningen 105(41): 2865Feldmeier, H.; Spangenberg, K.; Egger, M.; Heinrich, H. 1981: Analysis of drug prescriptions--the possibility of determining the justification of prescriptions and patient compliance Zeitschrift für Arztliche Fortbildung 75(18): 854-855
Springer, V.; Kisska, I.; Hrcková, M. 2002: Drug policy in Slovakia and its reflection in prescriptions. 1. Prescriptions for mass-produced drugs according to physician specialty Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 51(3): 129-133
Clancy, C. 2006: Off-label prescriptions: do we need more restraint or more evidence? Medgenmed: Medscape General Medicine 8(4): 56
Martin, R.M.; Wilton, L.V.; Mann, R.D.; Steventon, P.; Hilton, S.R. 1998: Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label Bmj 317(7152): 204
Howard, P.; Copland, J. 2013: Off-label, not off-limits: the FDA needs to create a safe harbor for off-label drug use Missouri Medicine 110(2): 106-109
Nittari, G.; Pallotta, G.; Pirillo, I.; Ricci, G.; Amenta, F. 2018: Evaluation of medical prescriptions and off-label use on board ships to improve healthcare quality European Review for Medical and Pharmacological Sciences 22(13): 4392-4400
Gardulf, A.; Bergman, U.; George, C.; Nordström, G. 2005: Computerize drug handling! Scrutiny of drug prescriptions at four emergency hospitals show big shortages Lakartidningen 102(22): 1732-1734; 1736-1737
Merlo, J.; Liedholm, H.; Lindblad, U.; Fält, J.ür.; Lindberg, G.; Melander, A. 2002: Better drug management can improve public health--a study of possible drug interactions by scrutinizing prescriptions dispensing by pharmacies Lakartidningen 99(9): 922-925
Leung, T.I.; Dumontier, M. 2015: Comparing Drug-Disease Associations in Clinical Practice Guideline Recommendations and Drug Product Label Indications Studies in Health Technology and Informatics 216: 1039
Agrest, A. 1996: Drug prescriptions Medicina 56(2): 204-205
Allebeck, P. 2005: Drug committees are necessary, according to the SNS reference group Lakartidningen 102(14): 1070
Walker, N. 1984: Sedative/hypnotic drug prescriptions New Zealand Medical Journal 97(754): 273
Teichner, H. 1977: Problems in the economy of drug prescriptions Fortschritte der Medizin 95(12): 757-758; 788
Asberg, K.Hulter. 2009: Drug committees' information leaflets are needed Lakartidningen 106(38): 2384
Kreck, C.; Saller, R. 1995: Expert evaluation of private drug prescriptions Gesundheitswesen 57(5): 258-263
Lilja, J. 1979: Drug product selection by formulary committees in Sweden American Journal of Hospital Pharmacy 36(8): 1042 1044
Rabøl, R.; Kampmann, J.Peter.; Christensen, H.R. 2004: Drug committees in Denmark. Status and future challenges Ugeskrift for Laeger 166(35): 2988-2991
Davoudian, M.-L. 2010: Planning drug prescriptions in digestive system surgery Revue de l'Infirmiere 160: 41-42
Dooley, A.G. 2007: Off-label drug use Medicine and Health Rhode Island 90(2): 63-65